Leuprorelin Implant

For the treatment of metastatic and locally advanced prostate cancer, endometriosis and advanced breast cancer.

Leuprorelin, like Goserelin, is an analogue of the hormone gonadoliberin. Inhibition of the release of sex hormones results in the same applications, prostate cancer, breast cancer and endometriosia.

AMW GmbH has independently developed leuprorelin implants with the dosage 11.25mg (three-month implant). In addition, further dosages are under development.

If you have any questions about our products,
contact us or send us an email to licensing@a-m-w.eu